• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HAN Huipu,XU Zhili,LI Li,WANG Yuedan,CHU Ming,ZHANG Mingbo.Virtual screening of Xanthine oxidase inhibitors contained in Yinlian Gout Granules[J].Journal Of Pharmaceutical Research,2020,39(5):269-271,277[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3771times   Download 3632次 QR Code for this article
Scan with your phone!
茵连痛风颗粒中黄嘌呤氧化酶抑制剂的虚拟筛选
韩慧璞1,徐志立1,李莉1,王月丹2,初明2,张明波1
Font:Larger+|Default|Smaller-
(1.辽宁中医药大学药学院,辽宁 大连 116600;2.北京大学医学部基础医学院,北京 100191)
摘要:
目的 探究中药复方茵连痛风颗粒中对黄嘌呤氧化酶有抑制作用的活性成分。方法 依据文献报道,建立了茵连痛风颗粒中所含化合物的结构数据库;以黄嘌呤氧化酶为靶标,使用AutoDock Vina 软件对这些化合物进行虚拟筛选,并用AutoDock Tool对代表性活性成分与黄嘌呤氧化酶的作用模式进行了分析。结果 茵连痛风颗粒所含物质中有13个化合物与黄嘌呤氧化酶的结合能在-9.0 kcal·mol-1以下,其中主要为黄酮类成分。结合模式分析表明这些活性分子可以与黄嘌呤氧化酶的活性位点形成-相互作用、疏水相互作用和氢键相互作用。结论 茵连痛风颗粒中含有黄嘌呤氧化酶抑制剂,可通过降低尿酸的生成发挥抗痛风作用。
关键词:  痛风  尿酸  黄嘌呤氧化酶  虚拟筛选
DOI:10.13506/j.cnki.jpr.2020.05.005
基金项目:辽宁省自然科学基金(No.2015020694)
Virtual screening of Xanthine oxidase inhibitors contained in Yinlian Gout Granules
HAN Huipu1,XU Zhili1,LI Li1,WANG Yuedan2,CHU Ming2,ZHANG Mingbo1
(1.Pharmaceutical College, Liaoning University of Traditional Chinese Medicine,Dalian 116600,China; 2.Department of Immunology, School of Basic Medical Sciences, Peking University, Beijing 100191,China)
Abstract:
Objective To investigate the Xanthine oxidase(XOD) inhibitors contained in compound Chinese medicine of Yinlian Gout Granules.Methods A molecular structure database was built based on the data from literature.The XOD inhibitors contained in the database were virtually screened with AutoDock software.The binding mode of representative active components to XOD was analyzed with AutoDock Tool. Results There are 13 compounds contained in Yinlian Gout Granules that can inhibit XOD with affinity energy less than -9.0 kcal·mol-1, most of which are flavonoids. Binding mode analysis showed that the interactions between active components and the active site of XOD included-interaction, hydrophobic interaction and hydrogen bonding interaction.Conclusion Yinlian Gout Granules contains inhibitors of XOD, and may play its role in the treatment of gout by reducing the formation of uric acid.
Key words:  Gout  Uric acid  Xanthine oxidase  Virtual screening
Today's Visits:492    Total Visits:2383211
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.